Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Jones

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Seminars in Liver Disease|May 1, 1981
Suspected drug-induced hepatic reactions reported to the FDA's adverse reaction system: an overviewJ K Jones
Clinical Pharmacology and Therapeutics|January 30, 2007
The Institute of Medicine's report on drug safety: constructive and ambitious, but does it go far enough?J K Jones
Annals of Internal Medicine|October 15, 1992
Assessing potential risk of drugs: the elusive targetJ K Jones
Drug Information Journal|December 13, 1978
Channels of drug informationJ K Jones
Family & Community Health|July 10, 1982
Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reportingJ K Jones
Pharmacoepidemiology and Drug Safety|January 23, 2002
Pharmacogenetics and pharmacoepidemiologyJ K Jones
Journal of Chromatographic Science|May 1, 1972
Report on AAFS activities in toxicologyJ K Jones
The West Indian Medical Journal|June 12, 2001
An evaluation of medical school education in musculoskeletal medicine at the University of the West Indies, BarbadosJ K Jones
Drug Information Journal|December 12, 1981
Post-marketing surveillance, annual reports and long term follow-upJ K Jones
The Journal of Rheumatology. Supplement|October 1, 1988
Definition of events associated with drugs: regulatory perspectivesJ K Jones
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Seminars in Liver Disease|May 1, 1981
Suspected drug-induced hepatic reactions reported to the FDA's adverse reaction system: an overviewJ K Jones
Clinical Pharmacology and Therapeutics|January 30, 2007
The Institute of Medicine's report on drug safety: constructive and ambitious, but does it go far enough?J K Jones
Annals of Internal Medicine|October 15, 1992
Assessing potential risk of drugs: the elusive targetJ K Jones
Drug Information Journal|December 13, 1978
Channels of drug informationJ K Jones
Family & Community Health|July 10, 1982
Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reportingJ K Jones
Pharmacoepidemiology and Drug Safety|January 23, 2002
Pharmacogenetics and pharmacoepidemiologyJ K Jones
Journal of Chromatographic Science|May 1, 1972
Report on AAFS activities in toxicologyJ K Jones
The West Indian Medical Journal|June 12, 2001
An evaluation of medical school education in musculoskeletal medicine at the University of the West Indies, BarbadosJ K Jones
Drug Information Journal|December 12, 1981
Post-marketing surveillance, annual reports and long term follow-upJ K Jones
The Journal of Rheumatology. Supplement|October 1, 1988
Definition of events associated with drugs: regulatory perspectivesJ K Jones
Pageof 13